SNP rs11185644 of RXRA gene is identified for dose-response variability to vitamin D3 supplementation: A randomized clinical trial

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Zhang, Mingzhi ^a,b   Zhao, Lan Juan ^b   Zhou, Yu ^b   Badr, Rhamee ^b   Watson, Patrice ^c   Ye, An ^b   Zhou, Boting ^c   Zhang, Jigang ^b   Deng, Hong Wen ^b   Recker, Robert R ^c   Lappe, Joan M ^c  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25-HYDROXYVITAMIN D; COLECALCIFEROL; RETINOID X RECEPTOR ALPHA; VITAMIN D;

ANALOGS AND DERIVATIVES; BLOOD; CONTROLLED STUDY; DIETARY SUPPLEMENT; DOSE RESPONSE; FEMALE; GENETICS; HUMAN; MIDDLE AGED; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; SINGLE NUCLEOTIDE POLYMORPHISM;

CHOLECALCIFEROL; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; RETINOID X RECEPTOR ALPHA; VITAMIN D;

EID: 85009495386     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep40593     Document Type: Article

References (61)

1. Weaver, C. M. & Fleet, J. C. Vitamin D requirements: current and future. Am J Clin Nutr 80, 1735S-1739S (2004).
2. Holick, M. F. et al. Evaluation, treatment, and prevention of Vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96, 1911-1930 (2011).
3. Rovner, A. J. & Miller, R. S. Vitamin D deficiency and insufficiency in children with osteopenia or osteoporosis. Pediatrics 122, 907-908 (2008).
4. Sahota, O. Osteoporosis and the role of Vitamin D and calcium-Vitamin D deficiency, Vitamin D insufficiency and Vitamin D sufficiency. Age Ageing 29, 301-304 (2000).
5. Hypponen, E. et al. Intake of Vitamin D and risk of type 1 diabetes: A birth-cohort study. Lancet 358, 1500-1503 (2001).
6. Afzal, S., Bojesen, S. E. & Nordestgaard, B. G. Low 25-HydroxyVitamin D and Risk of Type 2 Diabetes: A Prospective Cohort Study and Meta-analysis. Clin Chem 59, 381-391 (2013)
7. Kilkkinen, A. et al. Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol 170, 1032-1039 (2009).
8. Wang, L. et al. A prospective study of plasma Vitamin D metabolites, Vitamin D receptor gene polymorphisms, and risk of hypertension in men. Eur J Nutr 52, 1771-1779 (2013).
9. Tamez, H. & Thadhani, R. I. Vitamin D and hypertension: An update and review. Curr Opin Nephrol Hypertens 21, 492-499 (2012).
10. Moyano Peregrin, C., Lopez Rodriguez, F. & Castilla Castellano Mdel, M. Vitamin D and hypertension. Med Clin (Barc) 138, 397-401 (2012).
11. Karbasi, A. & Saburi, A. Vitamin D and breast cancer. Indian J Endocrinol Metab 16, 1047 (2012).
12. Bilinski, K. & Boyages, J. Association between 25-hydroxyVitamin D concentration and breast cancer risk in an Australian population: An observational case-control study. Breast Cancer Res Treat 137, 599-607 (2013).
13. Black, L. J. et al. Low Vitamin D levels are associated with symptoms of depression in young adult males. Aust N Z J Psychiatry 48, 464-471 (2014).
14. Ritterhouse, L. L. et al. Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann Rheum Dis 70, 1569-1574 (2011).
15. Kaptein, E. M. et al. Serum 25-hydroxyVitamin D deficiency; a risk factor for chronic kidney disease in ambulatory indigent patients. Endocr Pract 20, 236-243 (2014).
16. Rozita, M. et al. Serum Vitamin D levels in patients with chronic kidney disease. EXCLI J 12, 511-520 (2013).
17. Lappe, J. M., Davies, K. M., Travers-Gustafson, D. & Heaney, R. P. Vitamin D status in a rural postmenopausal female population. J Am Coll Nutr 25, 395-402 (2006).
18. Wang, T. T. et al. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyVitamin D3 target genes. Mol Endocrinol 19, 2685-2695 (2005).
19. Bouillon, R. et al. Vitamin D and human health: lessons from Vitamin D receptor null mice. Endocr Rev 29, 726-776 (2008).
20. Heaney, R. P. Optimal Vitamin D status. J Bone Miner Res 24, 755 (2009).
21. Aloia, J. F. et al. Vitamin D intake to attain a desired serum 25-hydroxyVitamin D concentration. Am J Clin Nutr 87, 1952-1958 (2008).
22. Avenell, A. et al. Vitamin D and Vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev 15, CD000227 (2009).
23. Avenell, A., Mak, J. C. & O'Connell, D. Vitamin D and Vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev 4, CD000227 (2014).
24. Nikooyeh, B. et al. Daily consumption of Vitamin D-or Vitamin D + calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: A randomized clinical trial. Am J Clin Nutr 93, 764-671 (2011).
25. Ahmed, W. et al. Low serum 25 (OH) Vitamin D levels (< 32 ng/mL) are associated with reversible myositis-myalgia in statin-treated patients. Transl Res 153, 11-16 (2009).
26. Didriksen, A. et al. The serum 25-hydroxyVitamin D response to Vitamin D supplementation is related to genetic factors, BMI, and baseline levels. Eur J Endocrinol 169, 559-567 (2013).
27. Zhou, C. et al. 1,25Dihydroxy Vitamin D(3) improves titanium implant osseointegration in osteoporotic rats. Oral Surg Oral Med Oral Pathol Oral Radiol 114, S174-S178 (2012).
28. Blum, M., Dallal, G. E. & Dawson-Hughes, B. Body size and serum 25 hydroxy Vitamin D response to oral supplements in healthy older adults. J Am Coll Nutr 27, 274-279 (2008).
29. Saliba, W., Barnett-Griness, O. & Rennert, G. The relationship between obesity and the increase in serum 25(OH)D levels in response to Vitamin D supplementation. Osteoporos Int 24, 1447-1454 (2013).
30. Barger-Lux, M. J. et al. Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int 8, 222-230 (1998).
31. Gallagher, J. C., Yalamanchili, V. & Smith, L. M. The effect of Vitamin D supplementation on serum 25(OH)D in thin and obese women. J Steroid Biochem Mol Biol 136, 195-200 (2013).
32. Ahn, J. et al. Genome-wide association study of circulating Vitamin D levels. Hum Mol Genet 19, 2739-2745 (2010).
33. Wang, T. J. et al. Common genetic determinants of Vitamin D insufficiency: A genome-wide association study. Lancet 376, 180-178 (2010).
34. Nimitphong, H. et al. Changes in circulating 25-hydroxyVitamin D according to Vitamin D binding protein genotypes after Vitamin D(3) or D(2)supplementation. Nutr J 12, 39 (2013).
35. Waterhouse, M. et al. Environmental, personal and genetic determinants of response to Vitamin D supplementation in older adults. J Clin Endocrinol Metab 99, E1332-E1340 (2014).
36. Fu, L. et al. Common genetic variants of the Vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyVitamin D [25(OH)D] to Vitamin D supplementation. Clin Biochem 42, 1174-1177 (2009).
37. Graafmans, W. C. et al. The effect of Vitamin D supplementation on the bone mineral density of the femoral neck is associated with Vitamin D receptor genotype. J Bone Miner Res 12, 1241-1245 (1997).
38. Shiraki, M. et al. Association of bone mineral density with apolipoprotein E phenotype. J Bone Miner Res 12, 1438-1445 (1997).
39. Kulah, E. et al. Effects of ACE gene polymorphism on Vitamin D therapy according to parathyroid hormone level in patients on hemodialysis. Adv Ther 23, 778-786 (2006).
40. Mori, S. et al. The implementation of personalized treatment for osteoporosis. Nihon Ronen Igakkai Zasshi 45, 655-659 (2008).
41. Hussein, A. G., Mohamed, R. H. & Alghobashy, A. A. Synergism of CYP2R1 and CYP27B1 polymorphisms and susceptibility to type 1 diabetes in Egyptian children. Cell Immunol 279, 42-45 (2012).
42. Wehr, E. et al. Vitamin D-associated polymorphisms are related to insulin resistance and Vitamin D deficiency in polycystic ovary syndrome. Eur J Endocrinol 164, 741-749 (2011).
43. Downie, D. et al. Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers. Clin Cancer Res 11, 7369-7375 (2005).
44. Cheng, J. B. et al. Genetic evidence that the human CYP2R1 enzyme is a key Vitamin D 25-hydroxylase. Proc Natl Acad Sci USA 101, 7711-7715 (2004).
45. Engelman, C. D. et al. Vitamin D intake and season modify the effects of the GC and CYP2R1 genes on 25-hydroxyVitamin D concentrations. J Nutr 143, 17-26 (2013).
46. Nissen, J. et al. Common variants in CYP2R1 and GC genes predict Vitamin D concentrations in healthy Danish children and adults. PLoS One 9, e89907 (2014).
47. Speeckaert, M. et al. Biological and clinical aspects of the Vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta 372, 33-42 (2006).
48. Yamamoto, K. et al. Conformationally restricted analogs of 1 alpha, 25-dihydroxyVitamin D3 and its 20-epimer: compounds for study of the three-dimensional structure of Vitamin D responsible for binding to the receptor. J Med Chem 39, 2727-2737 (1996).
49. Lauridsen, A. L. et al. Plasma concentrations of 25-hydroxy-Vitamin D and 1,25-dihydroxy-Vitamin D are related to the phenotype of Gc (Vitamin D-binding protein): A cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int 77, 15-22 (2005).
50. Engelman, C. D. et al. Genetic and environmental determinants of 25-hydroxyVitamin D and 1,25-dihydroxyVitamin D levels in Hispanic and African Americans. J Clin Endocrinol Metab 93, 3381-3388 (2008).
51. Janssens, W. et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the Vitamin D-binding gene. Thorax 65, 215-220 (2010).
52. Zhao, L. J. et al. Factors predicting Vitamin D response variation in non-Hispanic white postmenopausal women. J Clin Endocrinol Metab 97, 2699-2705 (2012).
53. Li, G. et al. Identification and characterization of the human retinoid X receptor alpha gene promoter. Gene 10, 118-127 (2006).
54. Arem, H. et al. Vitamin D metabolic pathway genes and pancreatic cancer risk. PLoS One 10, e0117574 (2015).
55. Powe, C. E. et al. Vitamin D-binding protein modifies the Vitamin D-bone mineral density relationship. J Bone Miner Res 26, 1609-1616 (2011).
56. Zhang, Y. et al. The GC, CYP2R1 and DHCR7 genes are associated with Vitamin D levels in northeastern Han Chinese children. Swiss Med Wkly 142, w13636 (2012).
57. Ritterhouse, L. L. et al. Vitamin D deficiency in a multiethnic healthy control cohort and altered immune response in Vitamin D deficient European-american healthy controls. PLoS One 9, e94500 (2014).
58. Williams, S. K. et al. Association of racial disparities in the prevalence of insulin resistance with racial disparities in Vitamin D levels: National Health and Nutrition Examination Survey (2001-2006). Nutr Res 33, 2662-2671 (2013).
59. Lappe, J. M. et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85, 1586-1591 (2007).
60. De La Vega, F. M., Isaac, H. I. & Scafe, C. R. A tool for selecting SNPs for association studies based on observed linkage disequilibrium patterns. Pac Symp Biocomput 11, 487-498 (2006).
61. Purcell, S. et al. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81, 559-575 (2007).